Analysis of accuracy of non-invasive hepatic fibrosis makers for diagnosing advanced hepatic fibrosis based on biopsy data from multinational patients with non-alcoholic fatty liver disease.
Not Applicable
Recruiting
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0007963
- Lead Sponsor
- Hanyang University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1634
Inclusion Criteria
Among adults aged 20 years or older who underwent liver biopsy between January 1, 1995 and March 30, 2021. people, both 1) who were diagnosed as having fatty liver and 2) whose degree of liver fibrosis was evaluated well, will be included in this study.
Exclusion Criteria
1) Under the age of 19
2) If patietns have other liver disease (viral hepatitis, liver cirrhosis, liver cancer, autoimmune liver disease, primary biliary cirrhosis, Wilson's disease, drug-induced hepatitis or liver damage)
3) Patients with malignant tumors
4) Patients who have the missing data for calculating five types of NITs (age, BMI, Impaired fasting glucose/diabetes, AST, ALT, GGT, platelet, serum albumin, total cholesterol)
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnostic accuracy of non-invasive tests for diagnosing advanced hepatic fibrosis
- Secondary Outcome Measures
Name Time Method Difference in diagnostic accuracy according to human race;Difference in diagnostic accuracy according to BMI (body mass index);Difference in diagnostic accuracy according to co-morbidity